Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 12-2023 | 09-2023 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 859,187 | 695,280 | 743,158 | 441,161 | 771,010 |
| Marketable Securities | 129,875 | 226,501 | 230,660 | 499,035 | 485,938 |
| Receivables | 962,266 | 1,023,380 | 977,509 | 901,681 | 880,570 |
| Inventories | 341,005 | 315,629 | 335,257 | 367,847 | 318,307 |
| Other current assets | 186,310 | 148,260 | 164,786 | 171,133 | 123,895 |
| TOTAL | $2,478,643 | $2,409,050 | $2,451,370 | $2,380,858 | $2,579,721 |
| Non-Current Assets | |||||
| PPE Net | 695,507 | 712,490 | 730,827 | 784,502 | 772,508 |
| Investments And Advances | 829,382 | 2,284,351 | 2,321,926 | 2,439,930 | 1,886,534 |
| Intangibles | 2,639,123 | 401,112 | 416,753 | 492,881 | 443,977 |
| Other Non-Current Assets | 293,011 | 256,727 | 260,965 | 266,531 | 214,086 |
| TOTAL | $4,457,023 | $3,654,680 | $3,730,471 | $3,983,844 | $3,317,106 |
| Total Assets | $6,935,661 | $6,063,730 | $6,181,834 | $6,364,709 | $5,896,827 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 960,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 388,378 | 361,162 | 365,514 | 378,855 | 349,306 |
| Other current liabilities | 189,933 | 119,061 | 138,248 | 190,866 | 124,080 |
| TOTAL | $1,617,568 | $610,014 | $697,059 | $668,045 | $649,906 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 86,240 | 70,264 | 73,078 | 79,643 | 76,027 |
| TOTAL | $93,050 | $77,092 | $80,088 | $86,980 | $83,035 |
| Total Liabilities | $1,710,624 | $687,106 | $777,147 | $755,032 | $732,947 |
| Shareholders' Equity | |||||
| Common Shares | 111,091 | 118,034 | 119,770 | 126,713 | 123,242 |
| Retained earnings | 4,964,377 | 5,332,683 | 5,294,611 | 5,283,309 | 4,918,184 |
| Other shareholders' equity | 442,773 | 430,538 | 433,302 | 469,884 | 386,186 |
| TOTAL | $5,225,043 | $5,376,624 | $5,404,687 | $5,609,678 | $5,163,880 |
| Total Liabilities And Equity | $6,935,667 | $6,063,730 | $6,181,834 | $6,364,710 | $5,896,827 |